Skip to main navigation
  • Search Aptevo.com
  • About Us
    • Management Team
    • Board of Directors
  • Our Technology
  • Pipeline
    • APVO436
    • ALG.APV-527
    • APVO603
    • Multiple Candidates
  • Investors

    Investors

    • Stock Details
    • News
    • Events
    • Presentations
    • Financial Reports
    • Corporate Governance
    • Investor FAQ
    • Investor Contacts
  • Careers
ADAPTIR immuno-oncology (I/O) biotech
Aptevo Therapeutics (NYSE:APVO)
Aptevo Therapeutics (NYSE:APVO)
  • Search Aptevo.com
  • About Us
    • Management Team
    • Board of Directors
  • Our Technology
  • Pipeline
    • Mipletamig
    • ALG.APV-527
    • APVO603
    • Multiple Candidates
  • Investors

    Investors

    • Stock Details
    • News
    • Events
    • Presentations
    • Financial Reports
    • Corporate Governance
    • Investor FAQ
    • Investor Contacts
  • Careers

Investors

Financial Information

  • SEC Filings
  • Annual Reports
  • Other Reports
  • Quarterly Results

SEC Filing Details

Document Details

Form
8-K
Filing Date
11/26/24
Document Date
11/26/24
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Aptevo Therapeutics Inc
Issuer
Aptevo Therapeutics Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Quick Links

  • Stock Details
  • News
  • Events
  • Presentations
  • Financial Reports
  • Analyst Coverage
  • Spin-out Tax Documentation
  • Corporate Governance
  • Investor FAQ
  • Investor Contacts

Tools

  • Print
  • RSS Feeds
  • E-mail Alerts
  • Home
  • About Us
  • Our Technology
  • Pipeline
  • Investors
  • Careers
  • Contact Us
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Aptevo Terms and Conditions

© 2024 Aptevo Therapeutics